Skye Bioscience, Inc. Stock Option, Exercise Price, Decrease
Skye Bioscience, Inc. (SKYE) reported Stock Option, Exercise Price, Decrease of $0.61 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceDecrease · last filed 2026-08-14
- Skye Bioscience, Inc. stock option, exercise price, decrease for the quarter ending 2026-03-31 was $0.61.
| Period end | Stock Option, Exercise Price, Decrease 3 month | Stock Option, Exercise Price, Decrease 6 month |
|---|---|---|
| 2026-06-30 | $0.61 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $0.61 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |